Related Experiment Video

Updated: Jul 19, 2026

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
09:17

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on: September 16, 2019

Suppression of multidrug resistance by migrastatin

Yasushi Takemoto1, Etsu Tashiro, Masaya Imoto

  • 1Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan.

The Journal of Antibiotics
|October 10, 2006
PubMed

Insights

Migrastatin (MGS) inhibits cancer cell migration and enhances chemotherapy effectiveness. This natural compound directly inhibits P-glycoprotein, overcoming drug resistance in cancer cells.

Area of Science:

  • Natural Product Chemistry
  • Molecular Pharmacology
  • Cancer Biology

Background:

  • Migrastatin (MGS) is a Streptomyces-derived metabolite known to inhibit cancer cell migration.
  • Multidrug resistance (MDR) in cancer is a significant clinical challenge, often mediated by efflux pumps like P-glycoprotein.
  • Overcoming P-glycoprotein-mediated drug resistance is crucial for improving chemotherapy efficacy.

Purpose of the Study:

  • To investigate the effect of Migrastatin (MGS) on the cytotoxicity of common anticancer drugs.
  • To determine if MGS can overcome P-glycoprotein-mediated drug resistance.
  • To elucidate the mechanism by which MGS affects drug-resistant cancer cells.

Main Methods:

  • Assessing the cytotoxicity of vinblastine, vincristine, and taxol in the presence of MGS in drug-resistant cell lines (VJ-300 and P388/VCR).
  • Quantifying intracellular concentrations of labeled anticancer drugs in cells treated with MGS.
  • Utilizing photolabeling assays with [3H]azidopine to detect MGS interaction with P-glycoprotein.

Main Results:

  • MGS significantly enhanced the cytotoxicity of vinblastine, vincristine, and taxol in P-glycoprotein-overexpressing cells.
  • MGS increased the intracellular accumulation of these anticancer drugs in resistant cell lines.
  • MGS directly inhibited the photolabeling of P-glycoprotein, indicating a physical interaction.

Conclusions:

  • Migrastatin (MGS) directly interacts with and inhibits P-glycoprotein.
  • MGS resensitizes multidrug-resistant cancer cells to conventional chemotherapeutic agents.
  • MGS represents a potential adjuvant therapy to overcome drug resistance in cancer treatment.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...